LIAISON CMV IgM Serum Control Set— 510(k) K161526

Substantially Equivalent

DiaSorin, Inc.

FDA 510(k) clearance K161526 for LIAISON CMV IgM Serum Control Set, Substantially Equivalent on 2016-06-30. Applicant: DiaSorin, Inc..

Clearance details

Applicant: DiaSorin, Inc.
Product code: Code JJX
Advisory panel: Clinical Chemistry
Date received: 2016-06-02
Decision date: 2016-06-30
Decision: Substantially Equivalent
Clearance type: Special
Location: Stillwater, MN, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code JJX

product code JJX

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.